Authors: Rajiv Kumar, Patrick T. Bunn, Siddharth Singh, Susanna S. Ng, Marcela Montes de, Fabian de Labastida Rivera, Shashi Bhushan Chauhan, Neetu Singh, Rebecca J. Faleiro, Chelsea L. Edwards, Teija Frame, Meru Sheel, Rebecca Austin, Steven Lane, Tobias Bald, Mark J. Smyth, Geoffrey R. Hill, Shannon E. Best, Ashraful Haque, Dillon Corvino, Nicola Waddell, Lambross T. Koufariotis, Pamela Mukhopadhay, Madhukar Rai, Jaya Chakravarty, Om Prakash Singh, David L. Sacks, Susanne Nylén, Jude E. Uzonna, Shyam Sundar, Christian Engwerda - Cell Reports 2020 cited by 73
T cell responses in mice and humans. Thus, manipulation of type I IFN signaling is a promising strategy for improving disease outcome in VL patients.
